pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

1,233 catalysts · 3,332 8k filing · 2,052 grant · 1,029 approval · 1,000 device adverse event · 743 device 510k · 584 earnings

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-10: 0 catalysts2026-08-11: 0 catalysts2026-08-12: 0 catalysts2026-08-13: 0 catalysts2026-08-14: 48 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 1 catalyst2026-08-18: 2 catalysts2026-08-19: 3 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts
view
agendamonth
sort
soonestlatesttypesponsoralpha
type: recall×type: approval×from 2026-01-18×clear all
type
  • 8k filing3,332
  • grant2,052
  • approval1,029
  • device adverse event1,000
  • device 510k743
  • earnings584
device pma
543
  • device recall277
  • recall204
  • phase 2 completion172
  • therapy area

    no tagged catalysts yet

    Week of Jan 12, 2026

    5
    ›Jan 18, 2026approval209d agoTOPIRAMATE — FDA approvaltopiramate ER

    Sponsor: GLENMARK PHARMS LTD. Form: CAPSULE. Route: ORAL

    full page →topiramate ER →fda approvals ↗
    ›Jan 18, 2026approval209d agoAMBRISENTAN — FDA approvalSigmapharm Laboratories LLC

    Sponsor: SUN PHARM. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 18, 2026approval209d agoAMBRISENTAN — FDA approvalSigmapharm Laboratories LLC

    Sponsor: SUN PHARM. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 18, 2026approval209d agoDOXYCYCLINE HYCLATE — FDA approvalDOXYCYCLINE HYCLATE

    Sponsor: MYLAN. Form: TABLET. Route: ORAL

    full page →DOXYCYCLINE HYCLATE →fda approvals ↗
    ›Jan 18, 2026approval209d agoDILTIAZEM HYDROCHLORIDE — FDA approvalBausch Health US LLC

    Sponsor: AMTA. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →fda approvals ↗

    Week of Jan 19, 2026

    45
    ›Jan 19, 2026approval208d agoAMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM) — FDA approvalUNASYN

    Sponsor: HQ SPECLT PHARMA. Form: INJECTABLE. Route: INJECTION

    full page →UNASYN →fda approvals ↗
    ›Jan 19, 2026approval
    ← prev
    page 1 of 25
    next →
    208d ago
    AMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM) — FDA approvalUNASYN

    Sponsor: HQ SPECLT PHARMA. Form: INJECTABLE. Route: INJECTION

    full page →UNASYN →fda approvals ↗
    ›Jan 19, 2026approval208d agoGLYCOPYRROLATE — FDA approvalFresenius Kabi USA LLC

    Sponsor: SUN PHARM INDS LTD. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 19, 2026approval208d agoGLYCOPYRROLATE — FDA approvalFresenius Kabi USA LLC

    Sponsor: CHARTWELL RX. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 20, 2026approval207d agoZEPBOUND (TIRZEPATIDE) — FDA approvalZEPBOUND

    Sponsor: ELI LILLY AND CO. Form: SOLUTION. Route: SUBCUTANEOUS

    full page →ZEPBOUND →fda approvals ↗
    ›Jan 20, 2026approval207d agoMIRABEGRON — FDA approvalAstellas Pharma US Inc

    Sponsor: ALKEM LABS LTD. Form: FOR SUSPENSION, EXTENDED RELEASE. Route: ORAL

    full page →fda approvals ↗
    ›Jan 20, 2026approval207d agoZIRGAN (GANCICLOVIR) — FDA approvalganciclovir

    Sponsor: BAUSCH AND LOMB. Form: GEL. Route: OPHTHALMIC

    full page →ganciclovir →fda approvals ↗
    ›Jan 20, 2026approval207d agoSERTRALINE HYDROCHLORIDE — FDA approvalGreenstone LLC

    Sponsor: UMEDICA. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Jan 20, 2026approval207d agoDOXYCYCLINE HYCLATE — FDA approvalPolyPid Ltd.

    Sponsor: HIKMA INTL PHARMS. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Jan 20, 2026approval207d agoDOXYCYCLINE HYCLATE — FDA approvalPolyPid Ltd.

    Sponsor: HIKMA INTL PHARMS. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Jan 20, 2026approval207d agoSERTRALINE HYDROCHLORIDE — FDA approvalSERTRALINE HYDROCHLORIDE

    Sponsor: NOVITIUM PHARMA. Form: CAPSULE. Route: ORAL

    full page →SERTRALINE HYDROCHLORIDE →fda approvals ↗
    ›Jan 20, 2026approval207d agoMOUNJARO (TIRZEPATIDE) — FDA approvalZEPBOUND

    Sponsor: ELI LILLY AND CO. Form: SOLUTION. Route: SUBCUTANEOUS

    full page →ZEPBOUND →fda approvals ↗
    ›Jan 20, 2026approval207d agoMETHYLPREDNISOLONE ACETATE — FDA approvalMETHYLPREDNISOLONE ACETATE

    Sponsor: SANDOZ. Form: INJECTABLE. Route: INJECTION

    full page →METHYLPREDNISOLONE ACETATE →fda approvals ↗
    ›Jan 20, 2026approval207d agoMETHYLPREDNISOLONE ACETATE — FDA approvalMETHYLPREDNISOLONE ACETATE

    Sponsor: SANDOZ. Form: INJECTABLE. Route: INJECTION

    full page →METHYLPREDNISOLONE ACETATE →fda approvals ↗
    ›Jan 20, 2026approval207d agoSITAGLIPTIN PHOSPHATE — FDA approvalSITAGLIPTIN PHOSPHATE

    Sponsor: APOTEX. Form: TABLET. Route: ORAL

    full page →SITAGLIPTIN PHOSPHATE →fda approvals ↗
    ›Jan 20, 2026approval207d agoSACUBITRIL AND VALSARTAN (SACUBITRIL) — FDA approvalSACUBITRIL AND VALSARTAN

    Sponsor: SOMERSET THERAPS LLC. Form: TABLET. Route: ORAL

    full page →SACUBITRIL AND VALSARTAN →fda approvals ↗
    ›Jan 20, 2026approval207d agoSERTRALINE HYDROCHLORIDE — FDA approvalSERTRALINE HYDROCHLORIDE

    Sponsor: APPCO. Form: CAPSULE. Route: ORAL

    full page →SERTRALINE HYDROCHLORIDE →fda approvals ↗
    ›Jan 21, 2026approval206d agoEVRYSDI (RISDIPLAM) — FDA approvalEVRYSDI

    Sponsor: GENENTECH INC. Form: TABLET. Route: ORAL

    full page →EVRYSDI →fda approvals ↗
    ›Jan 21, 2026approval206d agoEVRYSDI (RISDIPLAM) — FDA approvalEVRYSDI

    Sponsor: GENENTECH INC. Form: FOR SOLUTION. Route: ORAL

    full page →EVRYSDI →fda approvals ↗
    ›Jan 21, 2026approval206d agoEVRYSDI (RISDIPLAM) — FDA approvalEVRYSDI

    Sponsor: GENENTECH INC. Form: FOR SOLUTION. Route: ORAL

    full page →EVRYSDI →fda approvals ↗
    ›Jan 21, 2026approval206d agoTYENNE (TOCILIZUMAB-AAZG) — FDA approvalTYENNE

    Sponsor: FRESENIUS KABI USA. Form: INJECTABLE. Route: INTRAVENOUS

    full page →TYENNE →fda approvals ↗
    ›Jan 21, 2026approval206d agoVERQUVO (VERICIGUAT) — FDA approvalMerck & Co., Inc.

    Sponsor: MSD. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 21, 2026approval206d agoLACOSAMIDE — FDA approvalGlenmark Pharmaceuticals Ltd

    Sponsor: GLENMARK PHARMS. Form: SOLUTION. Route: INTRAVENOUS

    full page →fda approvals ↗
    ›Jan 21, 2026approval206d agoFENOFIBRATE — FDA approvalFENOFIBRATE

    Sponsor: MACLEODS PHARMS LTD. Form: TABLET. Route: ORAL

    full page →FENOFIBRATE →fda approvals ↗
    ›Jan 21, 2026approval206d agoCYCLOSPORINE — FDA approvalTWi Pharmaceuticals Inc

    Sponsor: TWI PHARMS. Form: EMULSION. Route: OPHTHALMIC

    full page →fda approvals ↗
    ›Jan 21, 2026approval206d agoBISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE (BISOPROLOL FUMARATE) — FDA approvalBISOPROLOL FUMARATE

    Sponsor: AUROBINDO PHARMA LTD. Form: TABLET. Route: ORAL

    full page →BISOPROLOL FUMARATE →fda approvals ↗
    ›Jan 21, 2026approval206d agoAVTOZMA (TOCILIZUMAB-ANOH) — FDA approvalAVTOZMA

    Sponsor: CELLTRION INC. Form: INJECTABLE. Route: IV (INFUSION)

    full page →AVTOZMA →fda approvals ↗
    ›Jan 21, 2026approval206d agoMICAFUNGIN SODIUM — FDA approvalSandoz Inc

    Sponsor: HISUN PHARM HANGZHOU. Form: INJECTABLE. Route: INTRAVENOUS

    full page →fda approvals ↗
    ›Jan 21, 2026approval206d agoBUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE (BUPRENORPHINE HYDROCHLORIDE) — FDA approvalBUPRENORPHINE HYDROCHLORIDE

    Sponsor: ASCENT PHARMS INC. Form: FILM. Route: BUCCAL, SUBLINGUAL

    full page →BUPRENORPHINE HYDROCHLORIDE →fda approvals ↗
    ›Jan 21, 2026recall206d agoGOLD STAR DISTRIBUTION INC recall (Cls II)IGC Pharma, Inc.

    TYLENOL a) 500 MG., 2'S DISPLAY, 50CT; b) COLD & FLU, 25CT/2S; c) COLD & FLU SEVERE, 2PK, 50CT; d) PM, 50CT; e) SINUS SEVERE, 2PK, 50CT — Reason: CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center. — Status: Ongoing

    full page →fda recalls ↗
    ›Jan 21, 2026recall206d agoGOLD STAR DISTRIBUTION INC recall (Cls II)

    LIQUID DAYQUIL 12/8oz — Reason: CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center. — Status: Ongoing

    full page →fda recalls ↗
    ›Jan 21, 2026recall206d agoGOLD STAR DISTRIBUTION INC recall (Cls II)GlaxoSmithKline LLC

    EXCEDRIN MIGRAINE 2'S- 25 CT — Reason: CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center. — Status: Ongoing

    full page →fda recalls ↗
    ›Jan 21, 2026recall206d agoGOLD STAR DISTRIBUTION INC recall (Cls II)

    Swan, White Clear Alcohol, 50%, 16oz, 12 count — Reason: CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center. — Status: Ongoing

    full page →fda recalls ↗
    ›Jan 21, 2026recall206d agoGOLD STAR DISTRIBUTION INC recall (Cls II)

    Personal Care, Vaporizing Chest Rub, 4 oz, 12 count, UPC 048155903319 — Reason: CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center. — Status: Ongoing

    full page →fda recalls ↗
    ›Jan 21, 2026recall206d agoGOLD STAR DISTRIBUTION INC recall (Cls II)

    Petroleum jelly: a) Vaseline Petroleum Jelly, 1.75, 12CT, UPC: 6001085120946; b) Vaseline Men Cooling Petroleum Jelly, 100ML, 12CT, UPC: 60022141; c) Vaseline Vitamin E, Petroleum Jelly, 100ML, 12CT, UPC: 6001085121028; MEN FRESH PETROLEUM JELLY, 100ML, 12CT, UPC: 60022127; d) Lucky Petroleum Jelly, 6 OZ, 12 PK, UPC: 808829081466;048155903562; e) Lucky Petroleum Jelly, COCOA, 6oz, 12ct, UPC: 808829081572, 048155922150; f) Personal Care, CREAMY PETROLEUM JELLY, 4.5oz, 12CT, UPC: 048155908642; g) Personal Care, CREAMY COCOA PETROLEUM JELLY, 4.5oz, 12CT, UPC: 048155922242; h) SOFTEE, PETROLEUM JELLY, 5oz, 12CT, UPC: 096002007208 — Reason: CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center. — Status: Ongoing

    full page →fda recalls ↗
    ›Jan 21, 2026recall206d agoGOLD STAR DISTRIBUTION INC recall (Cls II)Bayer HealthCare Pharmaceuticals Inc

    Aleve 1's, 60 CT — Reason: CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center. — Status: Ongoing

    full page →fda recalls ↗
    ›Jan 21, 2026recall206d agoGOLD STAR DISTRIBUTION INC recall (Cls II)

    TUMS a) Assorted, 12 Ct.; b) Extra Strength (EX) Assorted Berries, 12-count #1194A *05/27; c)Extra Strength (EX) Assorted Fruit, 12-count, #1194C *03/27 — Reason: CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center. — Status: Ongoing

    full page →fda recalls ↗
    ›Jan 21, 2026recall206d agoGOLD STAR DISTRIBUTION INC recall (Cls II)Balance Labs, Inc.

    MOTRIN 2'S DISP.- 50CT — Reason: CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center. — Status: Ongoing

    full page →fda recalls ↗
    ›Jan 21, 2026recall206d agoGOLD STAR DISTRIBUTION INC recall (Cls II)

    LUCKY ICE, Cool Mouthwash, Alcohol Free, 16.9oz, 12CT, UPC: 808829108989 — Reason: CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center. — Status: Ongoing

    full page →fda recalls ↗
    ›Jan 21, 2026recall206d agoGOLD STAR DISTRIBUTION INC recall (Cls II)

    Personal Care, Ice Gel, 8oz, 12 count, UPC 048155903463 — Reason: CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center. — Status: Ongoing

    full page →fda recalls ↗
    ›Jan 21, 2026recall206d agoGOLD STAR DISTRIBUTION INC recall (Cls II)GlaxoSmithKline LLC

    EXCEDRIN 2'S DISP.- 30 CT — Reason: CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center. — Status: Ongoing

    full page →fda recalls ↗
    ›Jan 21, 2026recall206d agoGOLD STAR DISTRIBUTION INC recall (Cls II)Aphios Corp

    Toothpaste: a) COLGATE, TOOTHPASTE, WHITENING, 2.5oz, 24ct; UPC: 035000511065; b) COLGATE, TOOTHPASTE, Regular, 2.5oz, 24ct, UPC: 035000511058; c) COLGATE, TOOTHPASTE, TRIPLE, 2.5oz, 24ct, UPC: 035000512109; d) COLGATE, TOOTHPASTE, MINT ZING, 24CT, 2.5oz, UPC: 035000744609; COLGATE, MAXFRESH, SPICY FRESH, RED TOOTH PASTE, 72CT, 150G; e) CREST, TOOTHPASTE, 40CT, 8.2OZ, UPC: 037000247081 — Reason: CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center. — Status: Ongoing

    full page →fda recalls ↗
    ›Jan 21, 2026recall206d agoSUN PHARMACEUTICAL INDUSTRIES INC recall (Cls III)TEVA PHARMACEUTICAL INDUSTRIES LTD

    Fluocinolone Acetonide Solution Topical Solution USP, 0.01%, 60-mL bottles, Rx only, Dist. by: Taro Pharmaceuticals Inc., Hawthorn, NY 10532. NDC 51672-1365-4 — Reason: Failed Impurities/Degradation Specifications: Out of specification result was obtained for the known impurity D. — Status: Ongoing

    full page →fda recalls ↗
    ›Jan 21, 2026recall206d agoGOLD STAR DISTRIBUTION INC recall (Cls II)Viatris Inc

    Deodorant: a) Axe, Body Spray, Wild Spice, 6CT, 150ML, UPC: 600108736469; b) LUCKY MENS STICK DEODORANT, SPRING FRESH, 24CT, 2.5 OZ, UPC: 808829111668; c) LUCKY MENS STICK DEODORANT, FRESH COMFORT, 24CT, 1.6 OZ, UPC: 808829089103; d) LADY DEODORANT, CHERRY BLOSSOSM, 24CT, 1.8oz, UPC: 048155921092; e) AXE, BODY SPRAY, APOLLO, 6CT, 150ML; f) AXE, BODY SPRAY, BLACK, 6CT, 150ML; g) AXE, BODY SPRAY, DARK TEMPTATION, 6CT, 150ML; h) AXE, BODY SPRAY, GOLD, 6CT, 150ML; i) AXE, BODY SPRAY, EXCITE, 6CT, 150ML; j) AXE, BODY SPRAY, ICE CHILL, 6CT, 150ML; k) AXE, BODY SPRAY, MUSK, 6CT, 150ML; l) AXE, DEODORANT SPRAY, ADRENALIN, 6CT, 150ML — Reason: CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center. — Status: Ongoing

    full page →fda recalls ↗
    ›Jan 21, 2026recall206d agoGOLD STAR DISTRIBUTION INC recall (Cls II)

    CHILDREN NYQUIL, COLD&FLU, BERRY, 8oz, 12ct — Reason: CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center. — Status: Ongoing

    full page →fda recalls ↗
    $BLCO16.980.00%
    $LLY1180.63-2.21%
    $LLY1180.63-2.21%
    $MRK135.84+0.21%
    $PYPD4.7500-0.63%
    $PYPD4.7500-0.63%
    $IGC0.2670+0.41%
    $BLNC
    $TEVA36.53+0.03%
    $VTRS16.14+0.59%